Numerous other molecular alterations contribute to the complexity of melanoma biology, including mutations of receptor tyrosine kinases ERBB4 and EPH, activation of vascular endothelial growth factor receptors (VEGFR), deregulation of p53, MITF expression, and the developmental signaling pathways Notch and Wnt (16-19). Here, TP53 is linked to melanoma.